Profile

Judd L. Walson, MD, MPH

Judd L. Walson, MD, MPH

Dr. Walson is an Associate Professor at the University of Washington. He completed his training in both Internal Medicine and Pediatrics Residencies at Duke University, a fellowship in Infectious Disease at the University of Washington, and holds a Masters in Public Health from Tufts University. Dr. Walson has extensive experience in the design and implementation of large clinical trials in resource-limited settings. He has worked extensively in Kenya, Ethiopia, Bangladesh, Thailand and Nepal.

Dr. Walson is particularly interested in the effect of enteric infection and composition on immunologic function and growth. Dr. Walson is the Principal Investigator for DeWorm3, which aims to demonstrate the feasibility of interrupting the transmission of soil transmitted helminths. Dr. Walson is also the Co-Director of CHAIN, a large clinical platform in five countries in Africa and Asia designed to evaluate mortality and morbidity among acutely ill children with varying degrees of malnutrition and to develop and test interventions for this high risk population. In addition to his clinical research, Dr. Walson is the Director of the Global Health Strategic Analysis and Research Training Program (START), an innovative collaboration between the Bill & Melinda Gates Foundation and the University of Washington.

Overview

Board Certification(s)

Pediatrics
Internal Medicine
Infectious Disease

Medical/Professional School

Tufts University School of Medicine, Boston
Tufts University School of Medicine, Boston, Public Health

Residency

Internal Medicine, Duke University School of Medicine, Durham

Fellowship

University of Washington, Seattle

Publications

  • Blish CA, Sangaré L, Herrin BR, Richardson BA, John-Stewart G, Walson JL
    Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection.
    20441516 The Journal of infectious diseases , 2010 June 15 : 1816-21
  • Walson JL, Stewart BT, Sangaré L, Mbogo LW, Otieno PA, Piper BK, Richardson BA, John-Stewart G
    Prevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults.
    20361031 PLoS neglected tropical diseases , 2010 Mar. 30 : e644
  • Greengrass V, Lohman B, Morris L, Plate M, Steele PM, Walson JL, Crowe SM
    Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients.
    19617845 Journal of acquired immune deficiency syndromes (1999) , 2009 Nov. 1 : 387-90
  • Walson JL, Herrin BR, John-Stewart G
    Deworming helminth co-infected individuals for delaying HIV disease progression.
    19588389 Cochrane database of systematic reviews (Online) , 2009 July 8 : CD006419
  • Walson JL, Otieno PA, Mbuchi M, Richardson BA, Lohman-Payne B, Macharia SW, Overbaugh J, Berkley J, Sanders EJ, Chung MH, John-Stewart GC
    Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
    18670219 AIDS (London, England) , 2008 Aug. 20 : 1601-9
  • Walson JL, John-Stewart G
    Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature.
    18160978 PLoS neglected tropical diseases , 2007 Dec. 19 : e102
  • Walson JL, Brown ER, Otieno PA, Mbori-Ngacha DA, Wariua G, Obimbo EM, Bosire RK, Farquhar C, Wamalwa D, John-Stewart GC
    Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up.
    17667334 Journal of acquired immune deficiency syndromes (1999) , 2007 Oct. 1 : 208-15